GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Piotroski F-Score

SanBio Co (TSE:4592) Piotroski F-Score : 2 (As of May. 22, 2024)


View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

SanBio Co has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for SanBio Co's Piotroski F-Score or its related term are showing as below:

TSE:4592' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 2   Max: 3
Current: 2

During the past 11 years, the highest Piotroski F-Score of SanBio Co was 3. The lowest was 2. And the median was 2.


SanBio Co Piotroski F-Score Historical Data

The historical data trend for SanBio Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Piotroski F-Score Chart

SanBio Co Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 2.00 - 2.00 2.00

SanBio Co Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 - - - 2.00

Competitive Comparison of SanBio Co's Piotroski F-Score

For the Biotechnology subindustry, SanBio Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SanBio Co's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where SanBio Co's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jan24) TTM:Last Year (Jan23) TTM:
Net Income was 円-2,644.33 Mil.
Cash Flow from Operations was 円-4,765.65 Mil.
Revenue was 円0.00 Mil.
Gross Profit was 円0.00 Mil.
Average Total Assets from the begining of this year (Jan23)
to the end of this year (Jan24) was (7045.114 + 5047.291) / 2 = 円6046.2025 Mil.
Total Assets at the begining of this year (Jan23) was 円7,045.11 Mil.
Long-Term Debt & Capital Lease Obligation was 円397.00 Mil.
Total Current Assets was 円4,937.37 Mil.
Total Current Liabilities was 円905.64 Mil.
Net Income was 円-5,559.58 Mil.

Revenue was 円0.00 Mil.
Gross Profit was 円0.00 Mil.
Average Total Assets from the begining of last year (Jan22)
to the end of last year (Jan23) was (5510.901 + 7045.114) / 2 = 円6278.0075 Mil.
Total Assets at the begining of last year (Jan22) was 円5,510.90 Mil.
Long-Term Debt & Capital Lease Obligation was 円665.00 Mil.
Total Current Assets was 円6,967.26 Mil.
Total Current Liabilities was 円1,090.27 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

SanBio Co's current Net Income (TTM) was -2,644.33. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

SanBio Co's current Cash Flow from Operations (TTM) was -4,765.65. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jan23)
=-2644.332/7045.114
=-0.37534268

ROA (Last Year)=Net Income/Total Assets (Jan22)
=-5559.584/5510.901
=-1.00883395

SanBio Co's return on assets of this year was -0.37534268. SanBio Co's return on assets of last year was -1.00883395. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

SanBio Co's current Net Income (TTM) was -2,644.33. SanBio Co's current Cash Flow from Operations (TTM) was -4,765.65. ==> -4,765.65 <= -2,644.33 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jan24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jan23 to Jan24
=397/6046.2025
=0.06566105

Gearing (Last Year: Jan23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jan22 to Jan23
=665/6278.0075
=0.10592533

SanBio Co's gearing of this year was 0.06566105. SanBio Co's gearing of last year was 0.10592533. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jan24)=Total Current Assets/Total Current Liabilities
=4937.37/905.639
=5.45180806

Current Ratio (Last Year: Jan23)=Total Current Assets/Total Current Liabilities
=6967.262/1090.274
=6.3903771

SanBio Co's current ratio of this year was 5.45180806. SanBio Co's current ratio of last year was 6.3903771. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

SanBio Co's number of shares in issue this year was 65.323. SanBio Co's number of shares in issue last year was 57.918. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0/0
=

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0/0
=

SanBio Co's gross margin of this year was . SanBio Co's gross margin of last year was . ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jan23)
=0/7045.114
=0

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jan22)
=0/5510.901
=0

SanBio Co's asset turnover of this year was 0. SanBio Co's asset turnover of last year was 0. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+0+1+0+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

SanBio Co has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

SanBio Co  (TSE:4592) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


SanBio Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of SanBio Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


SanBio Co (TSE:4592) Business Description

Traded in Other Exchanges
Address
8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines